I
Introductionintroduction
Glucagon is a 29-residue polypeptide hormone that is produced in the pancreas by the α-cells of the
islets of Langerhans. Glucagon is involved in maintaining normal levels of glucose in the blood by acting on liver glycogen, converting it to glucose. Glucagon is a stimulator of hepatic glycogenolysis, gluconeogenesis, and ketogenesis which are antagonistic effects to those of insulin action, resulting in increased blood glucose levels. Glucagon receptors have been found in liver, kidney, intestinal smooth muscle, brain and adipose tissue.
II
Principle of the Assay
principle of the assay
MSD® metabolic assays provide rapid and convenient methods for measuring the levels of protein targets within single small-volume samples. The assays are available in both singleplex and multiplex formats. In a singleplex assay, an antibody for a specific protein target is coated on one electrode (or “spot”) per well. In a multiplex assay, an array of capture antibodies against different targets is patterned on distinct spots in the same well. Our Human Glucagon Assay detects glucagon in a sandwich immunoassay (Figure 1). MSD provides a plate that has been pre-coated with glucagon antibody. The user adds the sample and a solution containing the labeled detection antibody—anti-glucagon labeled with an electrochemiluminescent compound, MSD SULFO-TAG label—over the course of one or more incubation periods. Glucagon in the sample binds to capture antibody immobilized on the working electrode surface; recruitment of the labeled detection antibody by bound analyte completes the sandwich. The user adds an MSD read buffer that provides the appropriate chemical environment for electrochemiluminescence and loads the plate into an MSD SECTOR instrument for analysis. Inside the SECTOR instrument, a voltage applied to the plate electrodes causes the labels bound to the electrode surface to emit light. The instrument measures intensity of emitted light to afford a quantitative measure of glucagon present in the sample.
Glucagon
SULFO-TAG labeled detection antibody Analyte Capture antibody
Figure 1. Sandwich immunoassay on MSD platform. The numbering convention for the different spots is
maintained in the software visualization tools, on the plate packaging, and in the data files. Any spot that is not coated with a specific capture antibody is blocked with BSA to reduce non-specific binding to that spot. A unique bar code label on each plate allows complete traceability back to MSD manufacturing records.
* human glucagon-like peptide-1 (GLP-1) analogue produced by recombinant DNA technology in Saccharomyces cerevisiae. For the full list of excipients, see...
Glucagon Glucose Glutamine gamma -Glutamyltransferase (GGT) Glycated hemoglobin ...(total) Human chorionic gonadotropin (HCG) Hydroxybutyric acid Hydroxyproline ...
Cortisol ? Glucagon ? Growth hormone ? Epinephrine ? Estrogen ? Progesterone...Available insulins are pork and human Age-Related considerations Type 1 DM ...
A local glucagon-like peptide Ellingsgaard, H., Hauselmann, I., et al. Interleukin-6 enhances 1 (GLP-1) system in human pancreatic islets. ...
a human glucagon - like peptide - 1 analogue,on cardiovascular risk biomarkers in patients with Type 2 diabetes〔J〕 Diabete Med, . 2008, 1 129 - 1...
The role of glucagon an fully of human diabetes, in insulinby time )athogenesis resistance , in spontaneous hypoglycemia , glythe cogen-storage disease , ...
T. Fan. Insight into the Bioactivity and Metabolism of Human Glucagon Receptor Antagonists from 3D-QSAR Analyses. QSAR Comb. Sci. 23:603-620, 2004. 6...
placebocontrolled phase II trial (NCT00696657) of semaglutide (Novo Nordisk), an acylated human glucagon-like polypeptide 1 (GLP-1) analogue for the ...
glucagon glucogenic amino acid glucogenic and ketogenic amino acid glucokinase ...human genome project, HGP human immuno-deficiency virus,HIV human leucocyte ...
(GLP-1) 人类胰高血糖素肽-1(human glucagon-like peptide-1, hGLP-1)是由人小肠L细胞分泌的多肽激素,是胰高血 糖素原在小肠中被加工后的产物,属肠降血糖...
热门文档